{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:31:26Z","timestamp":1740123086219,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The expression of macrophage inhibitory factor-1 (MIC-1) increases in patients with chronic hepatitis C (CHC), but whether MIC-1 level and its polymorphism affect the antiviral efficacy of CHC has not yet been reported. The present study aimed to investigate the association between MIC-1 polymorphism and antiviral efficacy in patients with CHC genotype 1b (CHC 1b). A total of 171 patients with CHC1b were recruited. The polymorphisms of rs1059369 and rs1059519 in<jats:italic>MIC-1<\/jats:italic>were detected by DNA sequencing. All patients received a standard dose of polyethylene glycol interferon\u2009+\u2009ribavirin (PR regimen), and divided into response, nonresponse, sustained virological response (SVR), and non-sustained virological response (NSVR) groups based on HCV RNA levels. The genotype distribution of the two single nucleotide polymorphisms (SNPs) did not differ between the response and nonresponse groups, SVR and non-SVR groups. However, the level of MIC-1 was positively correlated with ALT, AST, PIIINP, CIV, and<jats:italic>HCV<\/jats:italic>RNA (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Compared to before treatment, the level of MIC-1 in plasma was significantly decrease in the response group but not in the non-responsive group. Our results suggest that the level of MIC-1 in CHC1b is correlated with liver cell injury, liver fibrosis index, and viral load. However, the polymorphism of rs1059369 and rs1059519 may have negligible impact in expression of MIC-1 and efficacy of antiviral therapy in CHC patient.<\/jats:p>","DOI":"10.1007\/s11010-021-04097-2","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T18:13:46Z","timestamp":1613758426000},"page":"2439-2447","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of macrophage inhibitory factor -1 polymorphisms with antiviral efficacy of type 1b chronic hepatitis C"],"prefix":"10.1007","volume":"476","author":[{"given":"Songdao","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoting","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanmei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5984-1865","authenticated-orcid":false,"given":"Xunjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"key":"4097_CR1","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","volume":"61","author":"E Gower","year":"2014","unstructured":"Gower E, Estes C, Blach S et al (2014) Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 61:S45-57","journal-title":"J Hepatol"},{"issue":"4","key":"4097_CR2","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/hep.26141","volume":"57","author":"K Mohd Hanafiah","year":"2013","unstructured":"Mohd Hanafiah K, Groeger J, Flaxman AD et al (2013) Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seropreValence. J Hepatol 57(4):1333\u20131342","journal-title":"J Hepatol"},{"key":"4097_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2217\/fvl.13.11","volume":"8","author":"M Lemoine","year":"2013","unstructured":"Lemoine M, Nayagam S, Thursz M (2013) Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges. Future Virol 8:371\u2013380","journal-title":"Future Virol"},{"key":"4097_CR4","first-page":"906","volume":"3","author":"Chinese Society of Hepatology","year":"2015","unstructured":"Chinese Society of Hepatology (2015) Chinese Society of Infectious Diseases, guidelines for the prevention and treatment of Hepatitis C (2015 update). Chin J Liver Dis 3:906\u2013923","journal-title":"Chin J Liver Dis"},{"key":"4097_CR5","unstructured":"WHO. Guidelines for the screening, care and treatment of persons with hepatitis C infection EB\/OL. 2014-04 http:\/\/www.Who.Int\/hepatitis\/publications\/hepatitis-c-guidelines\/en\/"},{"key":"4097_CR6","first-page":"392","volume":"602","author":"European Association for Study of Liver","year":"2014","unstructured":"European Association for Study of Liver (2014) EASL clinical practice guidelines: management of hepatitis C virus infection. J Hepatol 602:392\u2013420","journal-title":"J Hepatol"},{"key":"4097_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1308\/003588412X13171221589856","volume":"94","author":"RR Brady","year":"2012","unstructured":"Brady RR, Ventham NT, Roberts DM et al (2012) Open transversus abdominis plane block and analgesic requirements in patients following right hemicolectomy. Ann R Coll Surg Engl 94:327\u2013330","journal-title":"Ann R Coll Surg Engl"},{"key":"4097_CR8","first-page":"232","volume":"83","author":"JX Shang Xu","year":"2015","unstructured":"Shang Xu JX, Chen X et al (2015) Efficacy of polyethylene glycol interferon-2a combined with Ribavirin in the treatment of chronic hepatitis C unresponsive patients and its influencing factors. J Chin J Clin Infect Dis 83:232\u2013237","journal-title":"J Chin J Clin Infect Dis"},{"key":"4097_CR9","doi-asserted-by":"crossref","first-page":"e002550","DOI":"10.1161\/JAHA.112.002550","volume":"1","author":"GA BonateITa","year":"2012","unstructured":"BonateITa GA, Ztigel S, Thogersen J et al (2012) Growth differentiation Factor-15 deficiency inhibits atherosclerosis progression by regulating interleukin-6 dependent inflammatory response tovascular injury. J Am Heart Assoc 1:e002550","journal-title":"J Am Heart Assoc"},{"key":"4097_CR10","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.109.928846","volume":"122","author":"IS Anand","year":"2010","unstructured":"Anand IS, Kempf T, Rector TS, Tapken H, Allhoff T, Jantzen F et al (2010) Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the valsartan heart failure trial. Circulation 122:1387\u20131395","journal-title":"Circulation"},{"key":"4097_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1373\/clinchem.2016.255174","volume":"63","author":"KC Wollert","year":"2016","unstructured":"Wollert KC, Kempf T, Wallentin L (2016) Growth differentiation factor 15 as a biomarker in cardiovascular disease. Clin Chem 63:140\u2013151","journal-title":"Clin Chem"},{"key":"4097_CR12","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.4238\/2015.March.27.8","volume":"14","author":"Z Zhu","year":"2015","unstructured":"Zhu Z, Sun T (2015) Association between growth differentiation factor-15 and chronic heart failure in in coronary atherosclerosis patients. Genet Mol Res 14:2225\u20132233","journal-title":"Genet Mol Res"},{"key":"4097_CR13","first-page":"869","volume":"21","author":"M Vocka","year":"2018","unstructured":"Vocka M, Langer D, Petrtyl J, Kalousova M, Zima T, Hanus T et al (2018) Growth differentiation factor 15 (GDF-15) as potential serum biomarkers in patients with metastatic colorectal cancer. J Clin Oncol 21:869\u2013874","journal-title":"J Clin Oncol"},{"key":"4097_CR14","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1093\/carcin\/bgi031","volume":"26","author":"W Wollmann","year":"2005","unstructured":"Wollmann W, Goodman ML, Bhat-Nakshatri P, Kishimoto H, Goulet RJ Jr, Mehrotra S, Morimiya A et al (2005) The macrophage inhibitory cytokine integrates AKT\/PKB and MAP kinase signaling pathways in breast cancer cells. Carcinogenesis 26:900\u2013907","journal-title":"Carcinogenesis"},{"key":"4097_CR15","doi-asserted-by":"crossref","first-page":"e13168","DOI":"10.1111\/eci.13168","volume":"49","author":"H Arfsten","year":"2019","unstructured":"Arfsten H, Cho A, Freitag C et al (2019) GDF-15 in solid vs non-solid treatment-na\u00efve malignancies. Eur J Clin Invest 49:e13168","journal-title":"Eur J Clin Invest"},{"key":"4097_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/490842","volume":"2015","author":"R Adela","year":"2015","unstructured":"Adela R, Banerjee SK (2015) GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective. J Diabetes Res 2015:1\u201314","journal-title":"J Diabetes Res"},{"key":"4097_CR17","first-page":"250","volume":"7","author":"Y Lu","year":"2014","unstructured":"Lu Y, Tao X, Zhou L (2014) Expression of Growth differentiation factor-15 in chronic hepatitis B and liver cirrhosis. Chin J Clin Infect Dis 7:250\u2013252","journal-title":"Chin J Clin Infect Dis"},{"key":"4097_CR18","doi-asserted-by":"publisher","first-page":"e0127518","DOI":"10.1371\/journal.pone.0127518","volume":"10","author":"X Liu","year":"2015","unstructured":"Liu X, Chi X, Gong Q, Gao L, Niu Y, Chi X et al (2015) Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma. PLoS ONE 10:e0127518","journal-title":"PLoS ONE"},{"key":"4097_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.5009\/gnl16049","volume":"11","author":"ES Lee","year":"2017","unstructured":"Lee ES, Kim SH, Kim HJ, Kim KH, Lee BS, Ku BJ (2017) Growth differentiation factor 15 predicts chronic liver disease severity. Gut Liver 11:276\u2013282","journal-title":"Gut Liver"},{"key":"4097_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jgeb.2017.08.004","volume":"15","author":"MH Halim","year":"2017","unstructured":"Halim MH, Abdulla NA, Kamel A, Abd El Maksoud N, Ragab HM (2017) Significance of growth differentiation factor 15 in chronic HCV patients. J Genet Eng Biotechnol 15:403\u2013407","journal-title":"J Genet Eng Biotechnol"},{"key":"4097_CR21","first-page":"14383","volume":"8","author":"R Jing","year":"2015","unstructured":"Jing R, Liu Q, Xie Q, Qian Z (2015) Correlation between GDF 15 gene polymorphism and the collateral circulation in acute non-ST segment elevated myocardial infarction. Int J Clin Exp Med 8:14383\u201314387","journal-title":"Int J Clin Exp Med"},{"key":"4097_CR22","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1590\/1806-9282.63.12.1049","volume":"63","author":"XP Chen","year":"1992","unstructured":"Chen XP, Shang XS, Wang YB, Fu ZH, Gao Y, Feng T (1992) (2017) Correlation between GDF-15 gene polymorphism and the formation of collateral circulation in acute ST-elevation myocardial infarction. Rev Assoc Med Bras 63:1049\u20131054","journal-title":"Rev Assoc Med Bras"},{"key":"4097_CR23","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.prp.2015.08.004","volume":"211","author":"J Wang","year":"2015","unstructured":"Wang J, Li W, Wang Y et al (2015) The H6D genetic variation of GDF15 is associated with genesis, progress and prognosis in colorectal cancer. J Pathol Res Pract 211:845\u2013850","journal-title":"J Pathol Res Pract"},{"key":"4097_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11427-009-0066-8","volume":"52","author":"Y Su","year":"2009","unstructured":"Su Y, Lin L, Tian G, Chen C, Liu T, Xu X, Qi X, Zhang X, Yang H (2009) Preparing a re-sequencing DNA library of 2 cancer candidate genes using the ligation-by-amplification protocol by two PCR reactions. Sci China C Life Sci 52:483\u2013491","journal-title":"Sci China C Life Sci"},{"key":"4097_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1177\/0391398817752326","volume":"41","author":"N Papadopoulos","year":"2018","unstructured":"Papadopoulos N, Griveas I, Sveroni E, Argiana V, Kalliaropoulos A, Martinez-Gonzalez B, Deutsch M (2018) HCV viraemia in anti-HCV-negative haemodialysis patients: do we need HCV RNA detection test? Int J Artif Organs 41:168\u2013170","journal-title":"Int J Artif Organs"},{"key":"4097_CR26","doi-asserted-by":"publisher","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","volume":"94","author":"MR Bootcov","year":"1997","unstructured":"Bootcov MR, Bauskin AR, VMenzuela SM, et al (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA 94:11514\u201311519","journal-title":"Proc Natl Acad Sci USA"},{"key":"4097_CR27","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1128\/MCB.20.10.3742-3751.2000","volume":"20","author":"EC Hsiao","year":"2000","unstructured":"Hsiao EC, Koniaris LG, Zimmers-Koniaris T et al (2000) Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury. Mol Cell Biol 20:3742\u20133751","journal-title":"Mol Cell Biol"},{"key":"4097_CR28","doi-asserted-by":"publisher","first-page":"276","DOI":"10.5009\/gnl16049","volume":"11","author":"ES Lee","year":"2017","unstructured":"Lee ES, Kim SH, Kim HJ et al (2017) Growth differentiation factor 15 predicts chronic liver disease severity. Gut Liver 11:276\u2013282","journal-title":"Gut Liver"},{"key":"4097_CR29","doi-asserted-by":"publisher","first-page":"e19967","DOI":"10.1371\/journal.pone.0019967","volume":"6","author":"Y Si","year":"2011","unstructured":"Si Y, Liu X, Cheng M et al (2011) Growth differentiation factor 15 is induced by hepatitis C virus infection and regulates hepatocellular carcinoma-related genes. PLoS ONE 6:e19967","journal-title":"PLoS ONE"},{"key":"4097_CR30","first-page":"629","volume":"23","author":"J Zhang","year":"2018","unstructured":"Zhang J, Guo Z, Su S (2018) Expression of Growth differentiation factor 15 in patients with chronic hepatitis C and its significance. J Liver 23:629\u2013631","journal-title":"J Liver"},{"key":"4097_CR31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4103\/0255-0857.188329","volume":"34","author":"P Ranjan","year":"2016","unstructured":"Ranjan P, Fletcher GJ, Radhakrishnan M et al (2016) Association of interleukin-28B rs12979860 and rs8099917 polymorphisms with sustained viral response in hepatitis C virus genotype 1 and 3 infected patients from the Indian subcontinent. Indian J Med Microbiol 34:335\u2013341","journal-title":"Indian J Med Microbiol"},{"key":"4097_CR32","doi-asserted-by":"crossref","first-page":"894","DOI":"10.20452\/pamw.3205","volume":"125","author":"AE Grzegorzewska","year":"2015","unstructured":"Grzegorzewska AE, Jodlowska E, Mostowska A et al (2015) Effect of interferon \u03bb3 gene polymorphisms, rs8099917 and rs12979860, on response to hepatitis B virus vaccination and hepatitis B or C virus infections among hemodialysis patients. Pol Arch Med Wewn 125:894\u2013902","journal-title":"Pol Arch Med Wewn"},{"key":"4097_CR33","first-page":"49","volume":"76","author":"L Zupin","year":"2016","unstructured":"Zupin L, Polesello V, Alberi G et al (2016) CD209 promoter polymorphisms associate with HCV infection and pegylated-interferon plus ribavirin treatment response. J MolImmunol 76:49\u201354","journal-title":"J MolImmunol"},{"key":"4097_CR34","doi-asserted-by":"publisher","first-page":"e7554","DOI":"10.1097\/MD.0000000000007554","volume":"96","author":"Z Liu","year":"2017","unstructured":"Liu Z, WangQi SW et al (2017) The relationship between ITPA rs1127354 polymorphisms and efficacy of antiviral treatment in Northeast Chinese CHC patients. Medicine (Baltimore) 96:e7554","journal-title":"Medicine (Baltimore)"},{"key":"4097_CR35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.humimm.2016.10.015","volume":"78","author":"B Swjatek-Koscielna","year":"2017","unstructured":"Swjatek-Koscielna B, Kaluzna E, Strauss E et al (2017) Interleukin 10 gene single nucleotide polymorphisms in Polish patients with chronic hepatitis C: analysis of association with severity of disease and treatment outcome. Hum Immunol 78:192\u2013200","journal-title":"Hum Immunol"},{"key":"4097_CR36","first-page":"171","volume":"133","author":"Z Mingliang","year":"2014","unstructured":"Mingliang Z, Jingtao G, Jiang Z, Zhiguo Z (2014) Association between growth differentiation factor-15 gene polymorphism + 157A \/ T and unstable angina pectoris. J Clin Exp Med 133:171\u2013174","journal-title":"J Clin Exp Med"},{"key":"4097_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1042\/CS20080637","volume":"118","author":"X Wang","year":"2010","unstructured":"Wang X, Yang X, Sun K et al (2010) The haplotype of the growth-differentiation factor 15 gene is associated with left ventricular hypertrophy in human essential hypertension. Clin Sci ( Lond) 118:137\u2013145","journal-title":"Clin Sci ( Lond)"},{"key":"4097_CR38","first-page":"960","volume":"3712","author":"He Qian","year":"2018","unstructured":"Qian He, Hongqi F, Liu Hong Xu, Bainan ZS, Songbo Fu (2018) Relationship between growth differentiation factor-15 polymorphism and susceptibility to chronic keshan disease. J Chin J Epidemiol 3712:960\u2013964","journal-title":"J Chin J Epidemiol"},{"key":"4097_CR39","unstructured":"Chen R (2012) Study on the relationship between growth factor-15 gene polymorphism and plasma level and coronary artery disease. Beijing Tsinghua University, Peking Union Medical College, Chinese Academy of Medical Sciences, 2012"},{"key":"4097_CR40","doi-asserted-by":"publisher","first-page":"6378","DOI":"10.3748\/wjg.v26.i41.6378","volume":"41","author":"XJ Yang","year":"2020","unstructured":"Yang XJ, Wang XO, Chen Y, Ye SD (2020) Associations of content and gene polymorphism of macrophage inhibitory factor-1 and chronic hepatitis C virus infection. World J Gastroenterol 41:6378\u20136390","journal-title":"World J Gastroenterol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04097-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-021-04097-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04097-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T14:02:01Z","timestamp":1724508121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-021-04097-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["4097"],"URL":"https:\/\/doi.org\/10.1007\/s11010-021-04097-2","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"type":"print","value":"0300-8177"},{"type":"electronic","value":"1573-4919"}],"subject":[],"published":{"date-parts":[[2021,2,18]]},"assertion":[{"value":"2 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}